ADC Therapeutics SA
ADCT
$3.10
-$0.01-0.32%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 20.92% | 34.07% | 34.25% | -17.53% | -16.55% |
| Total Depreciation and Amortization | -5.19% | -4.52% | 0.28% | 7.84% | 23.53% |
| Total Amortization of Deferred Charges | -67.43% | -78.06% | -70.09% | -61.85% | -49.21% |
| Total Other Non-Cash Items | -52.64% | -64.48% | -63.27% | 37.64% | -28.31% |
| Change in Net Operating Assets | 152.36% | -1,197.15% | -91.36% | 102.79% | 67.32% |
| Cash from Operations | 12.34% | 7.68% | -4.34% | 5.01% | -42.68% |
| Capital Expenditure | 63.20% | 78.03% | 73.04% | 64.42% | 41.24% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 63.20% | 78.03% | 73.04% | 6.84% | -99.10% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -5.09% | 13,944.11% | 12,703.10% | 12,697.55% | 1,402.22% |
| Repurchase of Common Stock | -229,100.00% | -204,100.00% | -204,100.00% | 36.09% | 99.93% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -100.00% | -100.00% |
| Cash from Financing | -7.39% | 31.38% | 31.38% | 38.03% | 35.91% |
| Foreign Exchange rate Adjustments | 8,966.67% | 132.69% | -145.11% | 49.82% | -98.22% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 24.97% | 48.09% | 42.04% | 48.71% | -61.92% |